Kazunari Sakagami - Concepedia

Author

Kazunari Sakagami

Taisho Pharmaceutical (Japan)

Also Known As

K Sakagami, Kazunari Sakagami, Sakagami, K.

Publications

528

Citations

H-Index

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)Kyoto University Tokyo University of Pharmacy and Life Sciences

About

Kazunari Sakagami is an author at Taisho Pharmaceutical (Japan) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	500
2	Biochemistry	5	5	250
3	Natural Sciences	3	3	216
4	Engineering	1	1	10
5	Social Sciences	1	1	250

Kazunari Sakagami

Publications

524

Citations

H-Index

Page 1

	Year	Citations
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota, Neuropharmacology Antidepressant-like ActivityPsychoactive DrugPsychiatryFunctional SelectivityMedicine	2003	250
Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists Atsuro Nakazato, Toshihito Kumagai, Kazunari Sakagami, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryPharmacological CharacterizationBiochemistryCompound 4	2000	114
Synthesis, in Vitro Pharmacology, Structure−Activity Relationships, and Pharmacokinetics of 3-Alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent and Selective Group II Metabotropic Glutamate Receptor Antagonists Atsuro Nakazato, Kazunari Sakagami, Akito Yasuhara, Journal of Medicinal Chemistry Combinatorial ChemistryPharmaceutical SciencePharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2004	59
Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): A potent and orally active group II mGluR antagonist with antidepressant-like potential Akito Yasuhara, Masato Nakamura, Kazunari Sakagami, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesPsychotropic Medication	2006	43
Synthesis, in vitro pharmacology, and pharmacokinetic profiles of 2-[1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid and its 6-heptyl ester, a potent mGluR2 antagonist Kazunari Sakagami, Akito Yasuhara, Shigeyuki Chaki, Bioorganic & Medicinal Chemistry Pharmacological StudyBiochemistryMedicinePharmacological AgentPharmacotherapy	2008	19
Synthesis, in vitro pharmacology, and structure–activity relationships of 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as mGluR2 antagonists Akito Yasuhara, Kazunari Sakagami, Ryoko Yoshikawa, Bioorganic & Medicinal Chemistry Molecular PharmacologyDerivativesBiochemistryMedicineMglur2 Antagonists	2006	15
IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND BIOAVAILABILITY OF ESTER PRODRUGS OF MGS0039 (3-(3,4-DICHLOROBENZYLOXY)-2-AMINO-6-FLUOROBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID), A POTENT METABOTROPIC GLUTAMATE RECEPTOR ANTAGONIST Masato Nakamura, Yasunori Kawakita, Akito Yasuhara, Drug Metabolism and Disposition	2005	14
Convenient method for the preparation of 1-phenylthio-3-alken-1-ynes and 4-hydroxy-1-phenylthio-1,2-alkadienes from a common precursor Atsushi Ogawa, Kazunari Sakagami, Akiko Shima, Tetrahedron Letters Common PrecursorEngineeringAlkene MetathesisConvenient MethodOrganic Chemistry	2002	10

Page 1